Yourgene Health PLC – YGEN – Directorate Change

Manchester, UK - 25 January 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces the appointment of Mary Tavener as a Non-executive Director ("NED") and Chair of the Audit Committee at Yourgene with effect from today.

Mary has extensive experience in the healthcare sector, having previously been Chief Financial Officer and board member of AIM listed Advanced Medical Solutions plc ("AMS") for 19 years during which the company saw 15 years of consecutive growth. Mary is a Member of the Chartered Institute of Management Accountants (ACMA) and a Fellow of the Association of Corporate Treasurers (FCT). Mary has a degree in Chemistry from the University of Oxford.

Mary is also a Senior Independent NED of Abingdon Health and NED for Allergy Therapeutics plc.

Separately the Group announces that Nick Mustoe has left the Board with immediate effect. We wish to thank Nick for all his support during his time at Yourgene and wish him the best for the future.

Adam Reynolds, Non-Executive Chairman, commented: "Mary has extensive experience within the life sciences sector on AIM, which will be invaluable to the Group as we grow and expand. I look forward to working alongside Mary as we continue to engage with our extensive pipeline of exciting opportunities.

"I would also like to thank Nick for his time and support of the Group. Nick has worked with Yourgene since the Company's IPO in 2014 and we have greatly benefitted from his expertise and guidance. Nick remains a supportive shareholder in Yourgene and I wish him all the best in his future endeavours."

Disclosures in accordance with the AIM Rules

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Mary Geraldine Tavener (aged 60):

Mary Tavener does not hold any share or options in the Company.